PER 2.35% 8.7¢ percheron therapeutics limited

Critics unfair on Diamond and Board.

  1. 13,062 Posts.
    lightbulb Created with Sketch. 1349
    Anp has been devalued like most stocks in the Biotech sector....Nasdaq.
    Anp has built a pipeline with 2 drugs in late stage.
    Anp has $5 mill in the Bank with Orphan Designation for Acromegaly being granted in the next 4 weeks...
    Anp ,only now with a good story re 2 drugs in late stage..something to sell to INVESTORS ..brought on board x2 big gun Directors from the Nasdaq with great Biotech EXPERIENCE.
    Anp in the next 2 months will be in a better position to put us on the World Biotech Map.Canges are coming within the Coy.
    Diamond and the Board are in the slow process of building a biotech Coy...
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.002(2.35%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.